GovChime
Notice ID: 61a2d74b04a24b78a499eef799c6d3a9Combined Synopsis/Solicitation

Venous Thrombosis (VT)

Active, responses due . Full description on SAM.gov.

Description

Amendment 003: 
The purpose of this amendment is to update the CLIN structure, add clauses, and attach Attachment E - Questions and Answers.
We have also extended the question due date to close on 10/30/2026 at 1:00PM CST  
We have not answered all questions recieved at this time, answers are still in works, please continue to monitor SAM.gov for updates. 

Amendment 002:
The purpose of this amendment is to fix admin errors on the CLIN. Please see SF30. 

Amendment 001: 
The purpose of this amendment  is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis". 

__________________________________________________

Base
Venous Thrombosis RFQ: 

This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued.

This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) .
The provisions and clauses in the RFQ are those in effect through FAC 2026-01
The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition.
All responsible sources may submit an offer which must be considered by the agency.
Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination.

The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV
NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf
Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference.

The items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.

FAR 52.212-2, Evaluation -- Commercial Products and Commercial Services
The Government will award a contract resulting from this solicitation to the offer responsible, whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors are in descending order of importance and must be used to evaluate offers: Technical Acceptability, Past Performance, and Price. Technical and Past Performance, when combined, are significantly more important than price.

FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services is applicable

NASA Clause 1852.215-84, Ombudsman, is applicable. The Center Ombudsman for this acquisition can be found at: https://www.hq.nasa.gov/office/procurement/regs/Procurement-Ombuds-Comp-Advocate-Listing.pdf

This posting, in addition to any attached documents, will be available on www.Sam.gov. Potential offerors will be responsible for downloading their own copy of this combination synopsis/solicitation and amendments (if any).

Prospective offerors are encouraged to notify this office of their intent to submit an offer. All contractual and technical questions must be submitted electronically via email to John Russo at john.d.russo@nasa.gov  and Katelyn Jaime at katelyn.r.jaime@nasa.gov not later than 1:00 PM CST on 10/30/2026. Telephone questions will not be accepted.

Responses to this combined synopsis/solicitation (with concurrence by the offeror’s institutional Authorized Organizational Official (AOR) if applicable) must be received via email no later than 1:00PM CST on 11/20/2026.

The Government is not responsible for any failure attributable to the transmission or receipt of documents submitted using electronic means, including the missing of any established deadlines.

Failure to submit a complete electronic proposal by the due date and time specified for this RFQ must result in the proposal being considered late and must be handled in accordance with FAR 52.212-1 Instructions to Offerors - Commercial Products and Commercial Services.

Full description on SAM.gov

Overview

Agency:
National Aeronautics and Space Administration
Office:NASA JOHNSON SPACE CENTER
Posted:October 28, 2026
NAICS:541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Last Updated:Oct 28, 2026
First published:
Last updated on SAM.gov:
PSC:AN22: R&D- MEDICAL: DRUG DEPENDENCY (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
Set-Aside:Not specified
Type:Combined Synopsis/Solicitation
Place of Performance:36208, Texas

Award Overview

Possible prior contracts

Sign in to see possible prior contracts for this requirement (matched by agency, NAICS and place of performance; not confirmed).

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (10)

  • VT - Attachment E - Questions and Answers 10.28.2026.pdf

    144 KBAdded in Combined Synopsis/Solicitation version 4Posted
    Download
  • Solicitation Amendment 80JSC026Q00140003 SF 30.pdf

    110 KBAdded in Combined Synopsis/Solicitation version 4Posted
    Download
  • Conformed - 80JSC026Q00140003.pdf

    978 KBAdded in Combined Synopsis/Solicitation version 4Posted
    Download
  • Solicitation Amendment 80JSC026Q00140002 SF 30.pdf

    101 KBAdded in Combined Synopsis/Solicitation version 3Posted
    Download
  • VT - Attachment C - Evaluation Criteria 9.25.2026.pdf

    141 KBAdded in Combined Synopsis/Solicitation version 2Posted
    Download
  • VT - Attachment A - PWS - 9.25.2026.pdf

    157 KBAdded in Combined Synopsis/Solicitation version 2Posted
    Download
  • VT - Attachment B - Additional Instructions 9.25.2026.pdf

    85 KBAdded in Combined Synopsis/Solicitation version 2Posted
    Download
  • VT - Attachment D - Pricing Sheet 9.25.2026.xlsx

    20 KBAdded in Combined Synopsis/Solicitation version 2Posted
    Download
  • Solicitation Amendment 80JSC026Q00140001 SF 30.pdf

    98 KBAdded in Combined Synopsis/Solicitation version 2Posted
    Download
  • Solicitation - 80JSC026Q0014.pdf

    973 KBAdded in Combined Synopsis/Solicitation version 2Posted
    Download

Lifecycle

  1. 1
    Version 1Combined Synopsis/Solicitation

    Venus Thrombosis (VT)

    Notice 923d781583ca4b8b8405fb9b516f2751 on SAM.gov

  2. 2
    Version 2Combined Synopsis/Solicitation

    Venous Thrombosis (VT)

    Notice 207bcf3cf3274a0db45479187d8c406b on SAM.gov

  3. 3
    Version 3Combined Synopsis/Solicitation

    Venous Thrombosis (VT)

    Notice e1baa77a8343447b8f7a952cc3fa3156 on SAM.gov

  4. 4
    Version 4Combined Synopsis/SolicitationCurrent

    Venous Thrombosis (VT)

    Notice 61a2d74b04a24b78a499eef799c6d3a9 on SAM.gov

Similar Opportunities

Title
Phase
Agency
NAICS
Set Aside
Posted
Deadline
Location

Additional Details

Solicitation Number

80JSC026Q0014

Archive Date

Dec 5, 2026

Office Address

HOUSTON, TX, 77058